<DOC>
	<DOCNO>NCT02192190</DOCNO>
	<brief_summary>The main purpose study test LY2951742 relieve mild moderate knee pain . The study drug give injection skin oral capsule . The study last 28 week participant .</brief_summary>
	<brief_title>A Study LY2951742 Participants With Mild Moderate Osteoarthritis Knee Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Have osteoarthritis ( OA ) knee joint base American College Rheumatology ( ACR ) criterion confirm Xrays ACR functional class I III Have stable dose prescription Nonsteroidal AntiInflammatory Drugs ( NSAIDS ) , celecoxib , tramadol , acetaminophen least 2000 mg per day least 20 day past month Willing stop analgesic OA pain study Experienced pain target knee base Visual Analog Scale ( VAS ) Allergic LY2951742 , celecoxib , NSAIDS , include aspirin , similar drug Arthritis knee cause Uncontrolled hypertension Have OA pain require treatment potent opioids , systemic corticosteroid , intraarticular injection , duloxetine , venlafaxine Moderate severe renal impairment Pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>